Company profile: Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

Sector: Healthcare

Industry: Drug Manufacturers - General

Full Time Employees: 47,000

Founded in 1876 by Civil War veteran Col. Eli Lilly

Headquartered in Indianapolis, Indiana

https://www.lilly.com

Eli Lilly & Co., now the biggest US drugmaker by market cap thanks to the success of its weight-loss drugs Mounjaro and Zepbound. 

Early Eli Lilly and Company advertisement, n.d. Credit: Encyclopedia of Indianapolis Collection, Eli Lilly & Co. Archives

Lilly quickly became one of the nation’s leading pharmaceutical manufacturers, hitting $1 million in sales by 1905. The company’s success came by making fundamental transformations in production and scientific research during the 1910s and 1920s, much of which was spurred by the two grandsons of Colonel Lilly, Eli Lilly and Josiah K. Lilly Jr. The company began an aggressive plant expansion in 1909 and later pioneered the introduction of modern, systematic management methods that increased output and lowered unit costs.